This content is machine translated Atherosclerosis Is there a need for new lipid-lowering drugs in the era of PCSK9 inhibitors? Recent progress Cardiovascular disease (CVD) remains the leading cause of death worldwide. Recent guidelines on HKE prevention highlight the extent to which elevated low-density lipoprotein cholesterol (LDL-C) is one of the most… CME-Test
